List view / Grid view

Whitepapers & App Notes

Advertorial: Next-generation microbial testing of pharmaceuticals

28 June 2024 | By

Specialised microbial testing is key in drug development to mitigate contamination risks, which threaten drug efficacy and patient safety. Bruker's MALDI Biotyper® at MPL, Austria, ensures accurate and robust testing, in a high-throughput workflow, delivering reproducible results.